Clinical Trial Update: Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study [NA]

View source ↗

Summary

This is a clinical trial update on the INFORM study evaluating multi-cancer early detection testing in a high-risk population; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genetic Predisposition to Cancer
• Hereditary Cancer Predisposition Syndrome

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Cancer Predisposition Syndrome, Predisposition, Genetic | NA | Status: RECRUITING